Darya Chudova - Feb 1, 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Stock symbol
GH
Transactions as of
Feb 1, 2025
Transactions value $
-$392,377
Form type
4
Date filed
2/4/2025, 05:14 PM
Previous filing
Jan 3, 2025
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +21.9K +38.66% $0.00 78.4K Feb 1, 2025 Direct
transaction GH Common Stock Tax liability -$392K -8.35K -10.65% $46.98 70.1K Feb 1, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Performance-Based Restricted Stock Units Options Exercise $0 -21.9K -100% $0.00 0 Feb 1, 2025 Common Stock 21.9K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the performance-based restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 Not applicable for Performance-Based Restricted Stock Units.